Vanilloid Receptor TRPV1, Sensory C-Fibers, and Vascular Autoregulation
- 12 November 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 95 (10) , 1027-1034
- https://doi.org/10.1161/01.res.0000148633.93110.24
Abstract
Myogenic constriction describes the innate ability of resistance arteries to constrict in response to elevations in intraluminal pressure and is a fundamental determinant of peripheral resistance and, hence, organ perfusion and systemic blood pressure. However, the receptor/cell-type that senses changes in pressure on the blood vessel wall and the pathway that couples this to constriction of vascular smooth muscle remain unclear. In this study, we show that elevation of intraluminal transmural pressure of mesenteric small arteries in vitro results in a myogenic response that is profoundly suppressed following ablation of sensory C-fiber activity (using in vitro capsaicin desensitization resulted in 72.8±10.3% inhibition, n=8; PPP1 receptors (66.3±13.7% inhibition, n=6; P<0.001), and not NK2 receptors (n=4, NS), almost abolished the myogenic response. Previous studies support a role for 20-hydroxyeicosatetraenoic acid (20-HETE) in myogenic constriction responses; herein, we show that 20-HETE–induced constriction of mesenteric resistance arteries is blocked by capsazepine. Together, these results suggest that elevation of intraluminal pressure is associated with generation of 20-HETE that, in turn, activates TRPV1 on C-fiber nerve endings resulting in depolarization of nerves and consequent vasoactive neuropeptide release. These findings identify a novel mechanism contributing to Bayliss’ myogenic constriction and highlights an alternative pathway that may be targeted in the therapeutics of vascular disease, such as hypertension, where enhanced myogenic constriction plays a role in the pathogenesis.Keywords
This publication has 31 references indexed in Scilit:
- Vascular Structural and Functional Changes in Type 2 Diabetes MellitusCirculation, 2002
- In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonistPublished by Elsevier ,2002
- Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)British Journal of Pharmacology, 2001
- The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing StimuliNeuron, 1998
- Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressureThe Journal of Physiology, 1998
- Pressure-induced activation of membrane K+ current in rat saphenous artery.Hypertension, 1992
- Ruthenium red blocks the capsaicin-induced increase in intracellular calcium and activation of membrane currents in sensory neurones as well as the activation of peripheral nociceptors in vitroNeuroscience Letters, 1990
- Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the ratNature, 1988
- Tachykinin-like immunoreactivity in the mammalian urinary bladder: Correlation with the functions of the capsaicin-sensitive sensory nervesNeuroscience, 1988
- Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptideEuropean Journal of Pharmacology, 1985